Oramed Pharmaceuticals, Inc

NASDAQ:ORMP  
15.43
-2.09 (-11.93%)
Products, Strategic Combinations

Oramed Subsidiary Oravax Medical And Genomma Lab Internacional Announce Joint Venture To Develop And Commercialize Oral COVID-19 Vaccine In Mexico

Published: 11/18/2021 12:50 GMT
Oramed Pharmaceuticals, Inc (ORMP) - Oramed Subsidiary Oravax Medical and Genomma Lab Internacional Announce Joint Venture to Develop and Commercialize Oral Covid-19 Vaccine in Mexico and Drive Business Development in Latin America.
Oramed Pharmaceuticals Inc - Announced a 50/50 Joint Venture Between Genomma Lab and Oramed's Subsidiary Oravax Medical Inc.